YISHENG PHARM released its 2024 annual performance, with a net profit attributable to the parent company of 52.0861 million yuan, a year-on-year decrease of 45.02%
YISHENG PHARM released its 2024 annual report, with operating revenue of 668 million yuan, a year-on-year decrease of 21.69%; net profit attributable to the parent company was 52.0861 million yuan, a year-on-year decrease of 45.02%. The net profit after deducting non-recurring gains and losses was 27.0646 million yuan, a year-on-year decrease of 64.33%. The basic earnings per share were 0.1574 yuan, and it plans to distribute a cash dividend of 1.00 yuan (tax included) for every 10 shares to all shareholders
According to the Zhitong Finance APP, YISHENG PHARM (002566.SZ) released its annual report for 2024. During the reporting period, the company achieved operating revenue of 668 million yuan, a year-on-year decrease of 21.69%. The net profit attributable to shareholders of the listed company was 52.0861 million yuan, a year-on-year decrease of 45.02%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 27.0646 million yuan, a year-on-year decrease of 64.33%. The basic earnings per share were 0.1574 yuan. It plans to distribute a cash dividend of 1.00 yuan (including tax) for every 10 shares to all shareholders
